An approach has been developed for the analysis of hepatitis B viral (HBV) antigenic structure that creates numerical "signatures" of HBV strains. This technique employs high-affinity IgM and IgG monoclonal antibodies (anti-HBsAg) directed toward distinct and separate determinants on hepatitis B surface antigen (HBsAg). Such antibodies have been used to develop sensitive and specific radioimmunoassays for measurement of HBsAg-associated determinants in serum. In performing "signature" analysis separate binding curves for each monoclonal anti-HBsAg are generated by measuring immunoreactivity in serial dilutions of HBsAg-positive serum. Since the HBsAg concentration in serum is unknown, the binding profiles of groups of samples from the same "classic" HBV subtype are aligned by an iterative maximum likelihood procedure to give the numerical signature of that HBV subtype. By using this approach, HBsAg shows far more antigenic heterogeneity than previously recognized by polyvalent anti-HBsAg antibodies. Indeed, there are subgroups within the classic HBsAg subtypes. In addition, the a domain (common to all known subtypes or strains of HBV) has been shown to be multideterminant. Thus, these studies have demonstrated heretofore unrecognized differences in HBV subtypes. This approach also has broader significance for the study of subtle or major antigenic changes among other viral agents since it is not necessary to know the concentration of virus or viral protein in complex protein mixtures.
Recent studies on viral antigenic structure using monoclonal antibodies suggest that there may be subtle but important antigenic differences among closely related viral strains. For example, the use of monoclonal antibodies has shown heterogeneity in the rabies virus; several rabies-related viral strains sharing common antigenic determinants have been identified (1) . Similar important structural modifications in viral determinants have been found in the influenza virus by means of monoclonal antibody binding differences (2) . Furthermore, there is a common antigenic relationship between herpes strains types 1, 2, and 3 and among the arenaviruses that can only be demonstrated by monoclonal antibodies (3) (4) (5) . In the present study, we report a technique called "signature" analysis that produces quantitative information on subtle and major antigenic differences among hepatitis B virus (HBV) strains and demonstrate the biologic significance of these findings.
MATERIALS AND METHODS The immunization protocols, cell fusion technique, and growth and cloning of hybridomnas producing anti-HBsAg antibodies (antibodies to hepatitis B surface antigen) have been reported (6) . The monoclonal anti-HBsAg antibodies have been characterized with respect to specificity for determinants on HBsAg, antibody class and subclass, and affinity for HBsAg-associated determinants (7) (8) (9) (10) (11) (12) (13) . Monoclonal antibodies designated 5C3 (IgG2a), 5C11, 2C6, 1C7, and 4E8 (IgGl), and 5D3, 1F8, and 2F11 (IgM) were selected from a library of monoclonal anti-HBsAg antibodies because of their following special properties-namely: (i) several bind to all known subtypes of HBsAg (by definition a domain epitopes; antibodies 5D3, 5C3, 5C11, and 2C6) (14) ; (ii) some demonstrate qualitative binding differences to ad and ay subtypes of HBsAg (antibodies 1F8, 2F11, 1C7, and 4E8) (6); (iii) they recognize distinct and separate determinants on HBsAg by competitive binding studies (9) ; and (iv) they possess very high affinitive constants for HBsAg-associated epitopes (range, 4.8 x 109 to 4 x 10l liters/mol per molecule).
RIAs. We employed eight monoclonal "simultaneous sandwich" RIAs for analysis of HBsAg-associated binding activity in the various HBsAg-positive serum samples. In brief, polystyrene beads were coated with a monoclonal IgM anti-HBsAg designated 5D3, and the other eight antibodies, including 5D3, were radiolabeled to a specific activity of 10-12 ,uCi/,ug of protein (1 Ci = 37 GBq) with the Hunter-Bolton reagent (15) . The 5D3-coated beads were incubated with serial 1:10 dilutions of serum samples (100 ,ul) and 100 ,ul of radiolabeled probe, consisting of =150,000 cpm of monoclonal anti-HBsAg for 4 hr at 45°C. The beads were washed extensively with distilled water, and the radioactivity bound to the bead was measured with a Packard gamma well counter.
In the present study we selected 64 serum samples representative of known HBsAg subtypes. These specimens have been classified as ayw2, ayw3, adw2, and adw4 HBsAg subtypes by RIA using conventional polyvalent anti-HBsAg antibodies (16) (17) (18) .
Data Analysis. The antigenic structure of a "classic" HBsAg subtype is characterized by its binding activities to the panel of eight monoclonal antibodies over a concentration range. For each serum sample, binding profiles are generated for the eight anti-HBsAg by plotting logeSIN (defined as the mean cpm bound in the experimental samples/mean cpm of the negative control serum) versus log10 dilution factor. In this data analytic step, using the sample binding profiles, statistical procedures have been developed to establish the structural "signatures" of each HBsAg subtype that is represented by the eight binding profiles. The statistical estimation of the binding profiles for a HBsAg subtype would have been standard if not for the fact that the absolute HBsAg concentration in any given sample cannot be effecAbbreviations: HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen.
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tively determined. Thus, we developed an iterative maximum likelihood procedure for aligning the HBsAg concentrations on different samples from the same classic HBsAg subtype as determined by polyvalent anti-HBsAg antibodies. Applying exploratory regression analysis to the aligned profiles of the subtypes, we have also found that the relationship between logS/N and the log1o dilution factor (d) for all profiles can be represented by the logistic function of the form:
logeSIN (x exp( bdi) [1 + exp(± b~i), [1] where bo, bl, b2, and b3 are binding parameters specific to a given HBsAg subtype and antibody. § RESULTS Definition of Classic HBsAg Subtypes by Signature Analysis. As shown in Fig. 1 We have also explored antigenic differences on the w domain by these eight monoclonal anti-HBsAg antibodies. For example, as shown in Fig. 3 , signature analysis was performed on two groups of individuals with adw2 and adw4 subtypes. In this experiment we controlled for the a and d locus and explored differences on the w2 and W4 domains. In contrast to the considerable epitope diversity observed between the d and y locus (Fig. 2) , there was remarkable homogeneity of the binding profiles when comparing adw2 (Fig. 3 Top) to adw4 (Fig. 3 Middle). The composite comparison is depicted in Fig. 3 Bottom and illustrates that antibodies 5D3, 5C3, 1C7, 2F11, 5C1l, and 1F8 have identical representation on both adw2 and adw4 viral strains. However, the two subtypes could be distinguished from each other by the qualita- tive differences exhibited by monoclonal antibodies 4E8 and 2C6.
Further support for the lack of extensive antigenic heterogeneity on the w domain was provided by the study of ayw3 and ayw2 subtypes. In this experiment we controlled the a and y domains and explored the differences between the W3 and w2 locus. As shown in Fig. 4 Bottom only antibody 1F8 demonstrated a minor antigenic difference between the ayw3 and ayw2 subtypes; the remaining seven monoclonal RIAs produced identical binding profiles of both subtypes.
Identification of Subgroups Within the Classic HBsAg Subtypes by Signature Analysis. During the study of a group of ayw3 individuals from the United States it became apparent that 7 of 25 individuals were different than the other 18 by signature analysis. Thus, we analyzed these 7 as a different group (Fig. 5) . It is noteworthy that these 7 when aligned give a set of distinctive binding profiles and were therefore defined as a distinct subgroup with its own signature (Fig. 5 Middle). We compared the signatures of the two groups of ayw3 individuals, as shown in Fig. 5 Bottom. Monoclonal antibodies 1C7, 4E8, and 2F11 gave identical binding profiles of both groups, whereas antibodies 5D3, 5C3, 2C6, 2F11, and 1F8 demonstrated qualitative differences between ayw3 and the new ayw3 subgroup. This study suggests viral antigenic heterogeneity within a classic ayw3 HBsAg subtype, and there are substrains of HBsAg heretofore unrecognized by polyvalent anti-HBsAg antibodies.
To further explore the significance of this observation, we studied a group of HBsAg-positive Australian aborigines previously classified as ayw3 by polyvalent anti-HBsAg antibodies (16) (17) (18) . This group is of particular interest, since it is from Mornington Island, an isolated settlement off the northern coast of Australia. This aborigine group probably repre sents a genetically stable homogenous population, since there is little interchange with the mainland (9) . Indeed, the HBsAg signature in 14 aborigine chronic HBV carriers was homogeneous, as shown in Fig. 6 Lower Left. Comparisons were made between the signature of ayw3 individuals from the United States and the aborigine group (Fig. 6 sons were made between the ayw3 and adw4 viral strains, monoclonal antibodies 2F11 and 1F8 demonstrated very low binding activity to the ayw3 subtype. These quantitative differences in monoclonal antibody binding activity are consistent with a reduction in the number of 2F11 and 1F8 epitopes on ayw3 leading to or contributing to the observed low binding result. However, the qualitative differences in binding profiles as manifested by a shift of the curves (e.g., antibody 2C6) are more difficult to interpret. We believe that a shift in the binding curve when comparing different subtype groups may be due, in part, to conformational changes in the epitope. Such conformational changes in antigenic structure appear common to all individuals who harbor a particular HBV strain. Alternatively, the qualitative differences in monoclonal anti-HBsAg binding profiles may be due to host factors such as glycosylation of HBsAg. This appears unlikely, since different HBsAg chronic carriers of the same subtype have identical signatures; serial studies show no change in the binding profiles over several years of observation. Furthermore, recent investigations suggest that vertical transmission of HBV from mother to child or horizontal spread within families breeds true-that is, all family members infected with HBV, including mother and child, have the identical signature (data not shown). Thus, signature analysis will be useful in epidemiologic studies of HBV transmission. The a domain has been defined as an antigenic region common to all known HBV subtypes (19) . We have found that most (>80%) of our high-affinity monoclonal antiHBsAg bind to all known HBsAg subtypes, although there were quantitative differences in the magnitude of binding activity. This observation suggests that the a domain is multi- (20) . In contrast, when the ad and ay domains were the same and the differences between the w specificities were examined, signature analysis demonstrated remarkable antigenic homogeneity among the w domains.
Further evidence of the antigenic diversity of HBV is supported by the demonstration of subgroups within the classic HBsAg subtypes. For example, ayw3 may now be divided into at least two separate subgroups. In the United States, an additional subgroup (Fig. 5) has been found to be distinct from the larger ayw3 group. Moreover, Australian aborigines are infected with an ayw3 strain that differs substantially from ayw3 groups or subgroups in the United States with respect to epitope composition and density. Thus, signature analysis may permit studies of the genetic evolution of HBV in various parts of the world. Indeed, preliminary studies of the ayw3 subtype from Africa and the Far East suggest additional viral strains distinct from those found in the United States and Australia (unpublished observations).
Comment is required on the structural composition of the signatures produced by the monoclonal RIAs at the molecular level. For example, as shown in Fig. 2 , when compari- I.,644~~~~~~l-P 
